Literature DB >> 18206553

Why meperidine should not make a comeback in treating patients with sickle cell disease.

Mary Ann Howland1, Lewis R Goldfrank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18206553     DOI： 10.1016/j.annemergmed.2007.05.021

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  1 in total

1.  Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.